跳至主要内容
临床试验/ISRCTN89698860
ISRCTN89698860已完成不适用

Prospective randomised comparison of granulocyte colony-stimulating factor (G-CSF) (filgrastim) secondary prophylaxis versus conservative management of chemotherapy-induced neutropenia to maintain dose intensity in chemotherapy for breast cancer

Anglo Celtic Cooperative Oncology Group (UK)0 个研究点目标入组 400 人开始时间: 2002年8月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. 18 years or older
  • 2. Histologically confirmed invasive breast cancer
  • 3. No concomitant malignancy
  • 4. No prior chemotherapy (apart from the current regimen)
  • 5. Previous neutropenic event on iv chemotherapy and considered of suitable risk and fitness to continue chemotherapy
  • 6. Written informed consent

排除标准

  • Not provided at time of registration

研究者

发起方
Anglo Celtic Cooperative Oncology Group (UK)

相似试验